Table 3. Intra- and inter-group comparison of participants' glycemic and lipid mean values. Picos, PI, Brazil, 2018.
| Variables | Before | After | Difference | p |
|---|---|---|---|---|
| Fasting blood sugar | ||||
| Control Group | 185.23 ± 74.16 | 175.98 ± 72.57 | -9.25 ± 48.44 | 0.041† |
| Experimental Group | 203.60 ± 88.24 | 174.05 ± 64.10 | -29.55 ± 53.76 | 0.001† |
| p-value | 0.297* | 0.931* | 0.130* | |
| HbA1c | ||||
| Control Group | 8.36 ± 1.89 | 8.29 ± 1.86 | -0.06 ± 1.05 | 0.361† |
| Experimental Group | 8.40 ± 1.96 | 8.14 ± 1.81 | -0.26 ± 1.05 | 0.144† |
| p-value | 0.853* | 0.721* | 0.765* | |
| Total cholesterol | ||||
| Control Group | 210.16 ± 57.53 | 202.07 ± 63.58 | -8.09 ± 75.32 | 0.040† |
| Experimental Group | 195.36 ± 46.59 | 183.74 ± 43.4 | -11.62 ± 30.55 | 0.010† |
| p-value | 0.160† | 0.073* | 0.884* | |
| HDL‡ | ||||
| Control Group | 50.00 ± 11.01 | 48.88 ± 10.1 | -1.13 ± 11.87 | 0.516† |
| Experimental Group | 48.04 ± 11.03 | 50.30 ± 10.9 | 2.26 ± 9.03 | 0.098† |
| p-value | 0.372† | 0.112* | 0.684* | |
| LDL§ | ||||
| Control Group | 126.79 ± 42.81 | 114.81 ± 57.06 | -11.97 ± 66.15 | 0.001† |
| Experimental Group | 114.21 ± 32.08 | 106.76 ± 28.43 | -7.45 ± 23.12 | 0.018† |
| p-value | 0.100† | 0.716* | 0.120* | |
| Triglycerides | ||||
| Control Group | 222.41 ± 130.95 | 217.71 ± 133.18 | -4.70 ± 92.67 | 0.712† |
| Experimental Group | 178.83 ± 94.96 | 174.19 ± 94.44 | -4.64 ± 62.16 | 0.958† |
| p-value | 0.072* | 0.131* | 0.776* | |
| HOMA-IR | ||||
| Control Group | 3.01 ± 1.91 | 3.20 ± 2.10 | 0.19 ± 1.75 | 0.563† |
| Experimental Group | 2.99 ± 2.10 | 3.21 ± 1.90 | 0.27 ± 2.27 | 0.251† |
| p-value | 0.770* | 0.830* | 0.586* |
*
Mann-Whitney's test;
†
Wilcoxon's test;
‡
HDL = HDL cholesterol;
§
LDL = LDL cholesterol; 95% confidence interval